| |
| | WGN 1997/2: News from the Industry Article 4 (Site not responding. Last check: 2007-10-10) |
 | | Losec®, 20 mg, amoxycillin, 1000 mg, and clarithromycin, 500 mg, all given twice daily for 7 days achieved an eradication rate of 95%, compared with 96% in the earlier MACH 1 study. |
 | | Furthermore, in patients treated with the same regimen, but without Losec®, the eradication rate was only 25%, underlining the central synergistic role of Losec® in facilitating the anti-H. pylori effect of the antibiotics. |
 | | Such 1-week Losec® triple therapy regimens have been endorsed as first line treatment for H. pylori-associated peptic ulcer disease in European Consensus Guidelines on the management of the infection, and have been approved by regulatory authorities in over 30 countries around the world. |
| www.omge.org /publications/archive/1997_2/indust9-97_4.html (192 words) |
|